188 related articles for article (PubMed ID: 18366723)
1. The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis.
Jiménez-Medina E; Berruguilla E; Romero I; Algarra I; Collado A; Garrido F; Garcia-Lora A
BMC Cancer; 2008 Mar; 8():78. PubMed ID: 18366723
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
3. A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation.
Jiménez-Medina E; Garcia-Lora A; Paco L; Algarra I; Collado A; Garrido F
BMC Cancer; 2006 May; 6():119. PubMed ID: 16677386
[TBL] [Abstract][Full Text] [Related]
4. Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells.
Mizutani Y; Nio Y; Yoshida O
J Urol; 1992 Nov; 148(5):1571-6. PubMed ID: 1433570
[TBL] [Abstract][Full Text] [Related]
5. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
6. Polysaccharide-K (PSK) increases p21(WAF/Cip1) and promotes apoptosis in pancreatic cancer cells.
Rosendahl AH; Sun C; Wu D; Andersson R
Pancreatology; 2012; 12(6):467-74. PubMed ID: 23217280
[TBL] [Abstract][Full Text] [Related]
7. Plant polysaccharide PSK: cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface.
Iguchi C; Nio Y; Takeda H; Yamasawa K; Hirahara N; Toga T; Itakura M; Tamura K
Anticancer Res; 2001; 21(2A):1007-13. PubMed ID: 11396133
[TBL] [Abstract][Full Text] [Related]
8. Protein-bound polysaccharide-K (PSK) induces apoptosis and inhibits proliferation of promyelomonocytic leukemia HL-60 cells.
Hirahara N; Fujioka M; Edamatsu T; Fujieda A; Sekine F; Wada T; Tanaka T
Anticancer Res; 2011 Sep; 31(9):2733-8. PubMed ID: 21868514
[TBL] [Abstract][Full Text] [Related]
9. Protein-bound polysaccharide-K (PSK) induces apoptosis via p38 mitogen-activated protein kinase pathway in promyelomonocytic leukemia HL-60 cells.
Hirahara N; Edamatsu T; Fujieda A; Fujioka M; Wada T; Tajima Y
Anticancer Res; 2012 Jul; 32(7):2631-7. PubMed ID: 22753720
[TBL] [Abstract][Full Text] [Related]
10. The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cells.
Vánky F; Wang P; Klein E
Cancer Immunol Immunother; 1992; 35(3):193-8. PubMed ID: 1638556
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
[TBL] [Abstract][Full Text] [Related]
12. Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells.
Hirose K; Zachariae CO; Oppenheim JJ; Matsushima K
Lymphokine Res; 1990; 9(4):475-83. PubMed ID: 2090874
[TBL] [Abstract][Full Text] [Related]
13. PSK induces apoptosis through the inhibition of activated STAT3 in human esophageal carcinoma cells.
Umehara S; Fujiwara H; Shiozaki A; Todo M; Furutani A; Yoneda M; Ikai A; Tada H; Komatsu S; Ichikawa D; Okamoto K; Ochiai T; Kokuba Y; Otsuji E
Int J Oncol; 2012 Jul; 41(1):61-6. PubMed ID: 22552778
[TBL] [Abstract][Full Text] [Related]
14. A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model.
Yamasaki A; Shoda M; Iijima H; Nagai S; Wada J; Suzuki H; Chikazawa N; Tasaka T; Kameda C; Tanaka H; Ikebe M; Jo E; Sato N; Nakamura M; Sekine F; Morisaki T; Katano M
Anticancer Res; 2009 Mar; 29(3):843-50. PubMed ID: 19414318
[TBL] [Abstract][Full Text] [Related]
15. Protein-bound polysaccharide-K induces apoptosis via mitochondria and p38 mitogen-activated protein kinase-dependent pathways in HL-60 promyelomonocytic leukemia cells.
Hirahara N; Edamatsu T; Fujieda A; Fujioka M; Wada T; Tajima Y
Oncol Rep; 2013 Jul; 30(1):99-104. PubMed ID: 23604455
[TBL] [Abstract][Full Text] [Related]
16. Competitive action of a biological response modifier, PSK, on a humoral immunosuppressive factor produced in tumor-bearing hosts.
Matsunaga K; Morita I; Iijima H; Endo H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1990 Mar; 31(3):127-36. PubMed ID: 1966997
[TBL] [Abstract][Full Text] [Related]
17. Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line.
Pedrinaci S; Algarra I; Garrido F
Int J Clin Lab Res; 1999; 29(4):135-40. PubMed ID: 10784373
[TBL] [Abstract][Full Text] [Related]
18. PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro.
Okuzawa M; Shinohara H; Kobayashi T; Iwamoto M; Toyoda M; Tanigawa N
Int J Oncol; 2002 Jun; 20(6):1189-95. PubMed ID: 12011998
[TBL] [Abstract][Full Text] [Related]
19. Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells.
Jiménez E; Garcia-Lora A; Martinez M; Garrido F
Cancer Immunol Immunother; 2005 Apr; 54(4):395-9. PubMed ID: 15602655
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of T-cell proliferation by PSK.
Hirai R; Oguchi Y; Sugita N; Matsunaga K; Nomoto K
Int J Immunopharmacol; 1993 Aug; 15(6):745-50. PubMed ID: 8407056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
